Kenny Roose

7PUBLICATIONS
80CO-AUTHORS
Innate immunityReaction engineering (excl. nuclear reactions)Animal cell and molecular biologyBiofabricationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2025
Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses.

Arne Matthys, Jan Felix, Joao Paulo Portela Catani

|Jun 13, 2023
Author Correction: Reverse engineering synthetic antiviral amyloids.

Emiel Michiels, Kenny Roose, Rodrigo Gallardo

|Oct 05, 2021
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

Bert Schepens, Loes van Schie, Wim Nerinckx

|Nov 18, 2020
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J F Kaptein

|Jun 07, 2020
Reverse engineering synthetic antiviral amyloids.

Emiel Michiels, Kenny Roose, Rodrigo Gallardo

|Aug 26, 2018
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes.

Lien Van Hoecke, Sandra Van Lint, Kenny Roose

Pageof 2